CY1116251T1 - MICHAEL SYSTEMS AS TRANSGLUTAMINE SUSPENSIONS - Google Patents

MICHAEL SYSTEMS AS TRANSGLUTAMINE SUSPENSIONS

Info

Publication number
CY1116251T1
CY1116251T1 CY20151100404T CY151100404T CY1116251T1 CY 1116251 T1 CY1116251 T1 CY 1116251T1 CY 20151100404 T CY20151100404 T CY 20151100404T CY 151100404 T CY151100404 T CY 151100404T CY 1116251 T1 CY1116251 T1 CY 1116251T1
Authority
CY
Cyprus
Prior art keywords
transglutamine
suspensions
michael systems
transglutaminase
compounds
Prior art date
Application number
CY20151100404T
Other languages
Greek (el)
Inventor
Kai Oertel
Original Assignee
Zedira Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE102006052755A external-priority patent/DE102006052755A1/en
Application filed by Zedira Gmbh filed Critical Zedira Gmbh
Publication of CY1116251T1 publication Critical patent/CY1116251T1/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Η εφεύρεση αφορά πεπτιδικά παράγωγα και πεπτιδομιμητικά ως αναστολείς τρανσγλουταμινασών. Η εφεύρεση αφορά επίσης μεθόδους για την παρασκευή των εν λόγω ενώσεων, φαρμακευτικές συνθέσεις που περιέχουν τις εν λόγω ενώσεις, καθώς και χρήσεις των εν λόγω αναστολέων τρανσγλουταμινασών, ειδικά για τη θεραπευτική αγωγή της κοιλιοκάκης και άλλων νόσων που σχετίζονται με τρανσγλουταμινάσες.The invention relates to peptide derivatives and peptidomimetics as transglutaminase inhibitors. The invention also relates to methods for the preparation of said compounds, pharmaceutical compositions containing said compounds, and uses of said transglutaminase inhibitors, especially for the treatment of celiac disease and other transglutaminase-related diseases.

CY20151100404T 2006-11-08 2015-05-08 MICHAEL SYSTEMS AS TRANSGLUTAMINE SUSPENSIONS CY1116251T1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102006052755A DE102006052755A1 (en) 2006-11-08 2006-11-08 New peptide derivatives and peptidomimetics are transglutaminase inhibitors useful for the treatment or prophylaxis of e.g. celiac disease, fibrosis, thrombosis, neurodegenerative disorders, Huntington's chorea and Parkinson disease
US87424606A 2006-12-12 2006-12-12
EP07846304.9A EP2086993B1 (en) 2006-11-08 2007-11-08 Michael systems as transglutaminase inhibitors

Publications (1)

Publication Number Publication Date
CY1116251T1 true CY1116251T1 (en) 2017-02-08

Family

ID=58457904

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20151100404T CY1116251T1 (en) 2006-11-08 2015-05-08 MICHAEL SYSTEMS AS TRANSGLUTAMINE SUSPENSIONS

Country Status (1)

Country Link
CY (1) CY1116251T1 (en)

Similar Documents

Publication Publication Date Title
CY1118454T1 (en) ORIGINAL PYROLLI INHIBITORS OF S-NITROZOGLUTATHYONE PRODUCTION AS THERAPEUTIC AGENTS
CY1119454T1 (en) ANTIBODIES AGAINST CD38 FOR TREATMENT OF MULTIPLE MYELOMA
CY1118012T1 (en) COMPOSITIONS OF CINASE DISEASES AND THEIR USE FOR THE PROTECTION OF CANCER AND OTHER DISEASES RELATED TO CHINESE
EA200970156A1 (en) PYRDISINOUS DERIVATIVES
CY1117995T1 (en) SECONDARY PRODUCTS OF CATEGOLAMIN AND MEDICINES CONTAINING THE THESE COMPOUNDS
CY1112781T1 (en) 2'-FLUORO-2'-DEOXYTETRAHYROIDURIDES AS CYTIDINE DISEASE INHIBITORS
CY1116377T1 (en) Suspensions of Human Tyrosine Protein Phosphate and Methods of Use
EA200971051A1 (en) INHIBITORS P70 S6 KINASE
CY1112828T1 (en) SUSPENSIONS UNION SUSPENDING PROCEDURES
ATE527253T1 (en) PYRIMIDINE-SUBSTITUTED BENZIMIDAZOLE DERIVATIVES AS PROTEIN KINASE INHIBITORS
CY1112453T1 (en) ANTIQUE UNIONS
EA201270553A1 (en) BLUTON TYROSINKINASE INHIBITORS
EA200901313A1 (en) BLUTON TYROSINKINASE INHIBITORS
CY1118665T1 (en) COMPOSITIONS AND METHODS FOR TREATMENT OF ALCOHOL, PAIN AND OTHER DISEASES
CY1114669T1 (en) Substituted Sulfonamide Derivatives
EA200870217A1 (en) 4-Aryl-2-aminopyrimidines or 4-aryl-2-aminoalkylpyrimidines as modulators JAK-2 and containing their pharmaceutical compositions
CY1112558T1 (en) N -MYTHYLAMINOMETHYL METHYL COMPOUNDS AND COMPOSITIONS INCLUDING THEIR METHODS OF USE
SE0301372D0 (en) Novel compounds
CY1111197T1 (en) TRIAZOLS USEFUL AS PROTEIN SUSPENDMENTS
EA201170227A1 (en) ИМИДАЗОЛКАРБОКСАМИДЫ
EA200900613A1 (en) SPIROKETONE ACETYL-COA-CARBOXYLAS INHIBITORS
CY1111269T1 (en) VR1 FUEL REGULATORS
EA201170441A1 (en) THERAPEUTIC ANTI-VIRAL PEPTIDES
EA201401193A1 (en) TRIAILARY COMPOUNDS AND COMPOSITIONS CONTAINING THEM
CL2008000021A1 (en) Compounds derived from 2,4-dianilinopyrimidines, protein kinase inhibitors; preparation procedure; pharmaceutical composition; and use for the treatment or prevention of inflammatory diseases, diabetes, and cancer.